The Washington Post, November 19, 2015. Precision medicine is the next big thing in health care, and it’s also one of the few health goals that Congress and the White House agree on. But while we await treatments targeting the precise genetic makeups of individuals and diseases, medical researchers still are not paying enough attention to the most important kinds of differences among patients: those of sex, age and race.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Experts Weigh In on 21st Century Cures Act
Medscape, November 18, 2015. Experts answer questions about the 21st Century Cures Act. Dr. Zuckerman shares why she believes the Act will allow unsafe and ineffective drugs to market.
Read More »Senate Counterpart to 21st Century Cures Bill is Struggling
Politico, October 25, 2015. The Senate’s companion effort to the House-passed 21st Century Cures is struggling to navigate a dramatically different political reality than the one that helped rocket the medical innovation bill through the lower chamber over the summer.
Read More »Approved But Not Proven: What’s Up with FDA Cancer Drugs?
Medscape Medical News, October 22, 2015. In approving new cancer drugs, the US Food and Drug Administration (FDA) is now heavily relying on surrogate markers of effectiveness, such as tumor shrinkage, instead of proof that an agent improves survival, according to a new analysis.
Read More »How Fast to “Cures” and at What Cost? Politico Forum Tilts Toward Pharma-Friendly Messaging
Health News Review, October 20, 2015. At an event entitled “How Fast to Cures?” hosted by Politico, the topic of discussion by four professionals from various realms of the research and health care advocacy world was the increasingly contentious 21st Century Cures Act.
Read More »